You must log in to view this page.

Enliven Therapeutics Inc. – Ownership Summary

NASDAQ: ELVN
Share price (5/22/26): $41.54
Market cap (5/22/26): $2.530 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Collins Helen Louise »

12/34/56

144

12/34/56

144

12/34/56

Hohl Benjamin »

12/34/56

144

12/34/56

≥5% Ownership

Venrock Healthcare Capital Partners III, L.P. »

SCHEDULE 13G/A

SCHEDULE 13G/A

SC 13G/A

SC 13G/A

SC 13G

Fairmount Funds Management LLC »

SCHEDULE 13G/A

SCHEDULE 13G/A

SCHEDULE 13G/A

SC 13G/A

SC 13G/A

Enliven Therapeutics Inc. – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Collins Helen Louise »

Hohl Benjamin »

≥5% Ownership

Venrock Healthcare Capital Partners III, L.P. »

Fairmount Funds Management LLC »

Enliven Therapeutics Inc. – Ownership Summary